ELOQUENT-2 Study in Japanese Patients - Safety was consistent with patients in relapsed refractory myeloma

ELOQUENT-2 Study in Japanese Patients - Safety was consistent with patients in relapsed refractory myeloma

ASHReport

2 years
97 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Mitsuo Hori, MD from Ibaraki Prefectural Central Hospital discusses ELOQUENT-2 study in Japanese patients safety was consistent with patients in relapsed refractory myeloma at the 2017 American Society of Hematology.
Up Next Autoplay